Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.1732
-0.0084 (-4.63%)
At close: Mar 20, 2026, 4:00 PM EDT
0.1767
+0.0035 (2.02%)
After-hours: Mar 20, 2026, 5:23 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $752.03 thousand as of March 20, 2026. Its market cap has decreased by -87.26% in one year.
Market Cap
752.03K
Enterprise Value
-2.15M
1-Year Change
-87.26%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $752.03K, a decrease of -99.64%. That is a compound annual growth rate of -78.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.29M | -49.91% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 1.94M |
| Propanc Biopharma | 1.79M |
| Dermata Therapeutics | 1.72M |
| Jaguar Health | 1.57M |
| CNS Pharmaceuticals | 1.42M |
| Clearmind Medicine | 989.89K |
| OKYO Pharma | 903.87K |
| CDT Equity | 793.03K |